Consideration in the management of renal cell carcinoma during the COVID-19 Pandemic

Conclusion: In the pandemic COVID -19 times, a tailored risk-based approach must be used for a safe management of RCC, aiming to not compromise the oncological outcomes of the patients.
Source: International Braz J Urol - Category: Urology & Nephrology Source Type: research